title: Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins.
abstract: Toll-like receptor 4 (TLR4) has been recently implicated in inflammatory pathways involved in carotid plaque destabilization. Given that statins have plaque stabilization and inflammation reduction effects, we investigated whether TLR4 expression on carotid atherosclerotic plaques correlates with statin intake. Carotid atherosclerotic plaques were obtained on 140 patients (preoperative statin intake, n = 70). TLR4 immunohistochemical expression was investigated in endothelial cells (ECs), macrophages (MACs) and smooth muscle cells (SMCs) of carotid atheroma. TLR4 positivity, over-expression and intensity of immunostaining were compared in statin versus no-statin users. The results of this study showed that statin users had a significantly lower expression of TLR4 in ECs (P = 0.02, 0.001, 0.006 for TLR4 positivity, increased intensity and over-expression, respectively). Similarly, TLR4 positivity was less pronounced in carotid plaque MACs of statin users (P = 0.03). No carotid specimen with increased EC TLR4 intensity or over-expression was observed among statin users. The prevalence of any cerebrovascular accident was 61.4% in the 'no statin' versus 18.6% in the 'statin' group (odds ratio for statin use: 0.14, 95% CI: 0.07-0.31, P < 0.001). In conclusion, statin treatment is associated with attenuated TLR4 expression on human carotid atherosclerotic plaques and a reduced risk of carotid-related cerebrovascular events. TLR4 may potentially mediate statins' plaque stabilization effects. Further investigation is necessary.
authors: st Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, Goudi, Athens, Greece. kthanassos@yahoo.com
authors: Athanasios
authors: A
authors: Katsargyris
authors: Chris
authors: C
authors: Klonaris
authors: Sotirios
authors: S
authors: Tsiodras
authors: Elias
authors: E
authors: Bastounis
authors: Athanasios
authors: A
authors: Giannopoulos
authors: Stamatios
authors: S
authors: Theocharis
mesh_terms: D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism; D002339:Carotid Arteries / Q000187:drug effects* / Q000378:metabolism* / Q000601:surgery; D016893:Carotid Stenosis / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism* / Q000601:surgery; D004691:Endarterectomy; D005260:Female; D006710:Homocysteine / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007150:Immunohistochemistry; D002546:Ischemic Attack, Transient / Q000453:epidemiology / Q000378:metabolism / Q000601:surgery; D008297:Male; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology / Q000378:metabolism / Q000601:surgery; D051197:Toll-Like Receptor 4 / Q000378:metabolism*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; D006710:Homocysteine; D002097:C-Reactive Protein